|
Volumn 51, Issue 3, 2008, Pages 185-190
|
Monitoring of serum levels of angiogenin, ENA-78 and GRO chemokines in patients with renal cell carcinoma (RCC) in the course of the treatment.
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOGENIC FACTOR;
ANGIOGENIN;
CXCL1 CHEMOKINE;
EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78;
PANCREATIC RIBONUCLEASE;
ADULT;
AGED;
ARTICLE;
BLOOD;
FEMALE;
HUMAN;
KIDNEY CARCINOMA;
KIDNEY TUMOR;
MALE;
MIDDLE AGED;
PATHOLOGY;
ADULT;
AGED;
ANGIOGENESIS INDUCING AGENTS;
CARCINOMA, RENAL CELL;
CHEMOKINE CXCL1;
CHEMOKINE CXCL5;
FEMALE;
HUMANS;
KIDNEY NEOPLASMS;
MALE;
MIDDLE AGED;
RIBONUCLEASE, PANCREATIC;
|
EID: 63249107726
PISSN: 12114286
EISSN: None
Source Type: Journal
DOI: 10.14712/18059694.2017.22 Document Type: Article |
Times cited : (4)
|
References (0)
|